Ftse Mib
34.116,63
-0,75%
DAX
18.485,34
-0,62%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.700,96
-3,32%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Processa Pharmaceuticals Inc (PCSA) Processa Pharmaceuticals Inc (PCSA) Notizie

PCSA

Processa Pharmaceuticals (PCSA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PCSA
DataOraFonteTitoloSimboloCompagnia
25/03/202121:06GlobeNewswire Inc.Processa Pharmaceuticals Announces Year end 2020 Results and Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
22/03/202114:15GlobeNewswire Inc.Processa Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter Results and Provide Drug Development Update on M...NASDAQ:PCSAProcessa Pharmaceuticals Inc
17/03/202114:15GlobeNewswire Inc.Processa Announces Sites Selected for Phase 2B Clinical Trial to Treat Patients with Ulcerated Necrobiosis LipoidicaNASDAQ:PCSAProcessa Pharmaceuticals Inc
02/03/202115:15GlobeNewswire Inc.Processa Pharmaceuticals Announces Closing of a $10.2 Million Private PlacementNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/02/202115:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PCSAProcessa Pharmaceuticals Inc
18/02/202116:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PCSAProcessa Pharmaceuticals Inc
17/02/202114:00GlobeNewswire Inc.Processa Pharmaceuticals Announces $10.2 Million Strategic FinancingNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/01/202116:50GlobeNewswire Inc.Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
16/11/202018:47GlobeNewswire Inc.Processa Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/11/202022:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PCSAProcessa Pharmaceuticals Inc
12/11/202023:01GlobeNewswire Inc.Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
12/11/202022:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/11/202015:15GlobeNewswire Inc.Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of DirectorsNASDAQ:PCSAProcessa Pharmaceuticals Inc
03/11/202015:20GlobeNewswire Inc.Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on N...NASDAQ:PCSAProcessa Pharmaceuticals Inc
14/10/202000:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
13/10/202020:23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PCSAProcessa Pharmaceuticals Inc
13/10/202015:30GlobeNewswire Inc.Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating OfficerNASDAQ:PCSAProcessa Pharmaceuticals Inc
06/10/202022:05GlobeNewswire Inc.Processa Pharmaceuticals Closes $19.2 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
05/10/202023:32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/10/202022:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:PCSAProcessa Pharmaceuticals Inc
05/10/202015:15Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:PCSAProcessa Pharmaceuticals Inc
02/10/202012:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PCSAProcessa Pharmaceuticals Inc
02/10/202012:00GlobeNewswire Inc.Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital MarketNASDAQ:PCSAProcessa Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PCSA

La tua Cronologia

BIT
P223I6
NLBNPIT223I6 20991231 33...
BIT
UC80K9
Unicredit Bank
LSE
0ROQ
Comet
LSE
IGR
Ig Design
TSX
PRV.UN
Pro Real Estate Investment
BIT
P1PVW9
BNP Paribas Issuance
NASDAQ
MARKP
Remark
NASDAQ
APMI
AxonPrime Infrastructure...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network